Targeting ferroptosis for treatment of Alzheimer' s disease
- Author:
Hui-Yan SUN
1
;
Hui-Yan SUN
2
;
Qiang LI
3
;
Hong-Quan WANG
4
Author Information
- Publication Type:Journal Article
- Keywords: Alzheimer' s disease; ferroptosis; ferroptosis inhibitor; iron dyshomeostasis; lipid peroxidation; neuroprotection
- From: Chinese Pharmacological Bulletin 2024;40(2):229-233
- CountryChina
- Language:Chinese
- Abstract: Alzheimer' s disease (AD) is a progressive neurodegenerative disorder histologically characterized by the presence of senile plaques and neurofibrillary tangles (NFTs) found in and around pyramidal neurons in cortical tissue. Mounting evidence suggests regional increased iron load and dyshomeostasis have been associated with oxidative stress, oxidation of proteins and lipids, and cell death, and appears to be a risk factor for more rapid cognitive decline, thereby involved in multiple aspects of the pathophysiology of AD. Ferroptosis is a newly identified iron-dependent lipid peroxidation-driven cell death and emerging evidences have demonstrated the involvement of ferroptosis in the pathological process of AD. Notably, some novel compounds targeting ferroptosis can relieve AD-related pathological symptoms in AD cells and animal model and exhibit potential clinical benefits in AD patients. This review systematically summarizes the growing molecular and clinical evidence implicating ferroptosis in the pathogenesis of AD, and then reviews the application of ferroptosis inhibitors in mouse/cell models to provide valuable information for future treatment and prevention of AD.
